What Fasciotens does

Fasciotens is a Cologne, Germany-based medical device company founded in 2016 that develops and commercializes proprietary devices for abdominal wall reconstruction using controlled mechanical fascial traction. Its product portfolio comprises three specialized devices targeting distinct clinical indications: fasciotens® Abdomen for open abdomen therapy in intensive care settings, fasciotens® Hernia for complex hernia repair (including large, recurrent, and loss-of-domain hernias), and fasciotens® Pediatric for congenital abdominal wall defects such as gastroschisis and omphaloceles in newborns. The technology was developed by surgeons and is differentiated by its standardized, reproducible approach to fascial closure, with documented case outcomes including closure of a 25 cm midline incisional hernia recurrence and a 16 cm hernia without component separation. The company holds a registered trademark on the fasciotens® brand.

The company sells its devices primarily through direct hospital engagement supplemented by a network of local distribution partners, targeting surgical departments, ICUs, and neonatal/pediatric surgical units. Its go-to-market combines enterprise field sales with significant clinical education investments — congress participation, surgeon workshops, the academy.fasciotens.com e-learning platform, and case discussion consultation services — reflecting the surgeon-led, education-intensive nature of medical device adoption. Pricing is not publicly disclosed and appears to be quote-based, consistent with hospital procurement norms for surgical hardware. Named reference customers include Hospital Agatharied Hausham and Hospital Agaplesion Elisabethstift Darmstadt in Germany.

Fasciotens has raised approximately €3.06 million in a 2018 round with coparion as a disclosed investor and was accepted into the MedTech Innovator accelerator in May 2024. The company remains privately held with 11–50 employees, no parent company or subsidiaries identified, and no disclosed revenue. No AI/ML, software, or digital platform capabilities are referenced in the available data.

Name

Fasciotens

Legal name

Fasciotens

Website

https://fasciotens.de

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Fasciotens is a Cologne-based medical device company developing proprietary fascial traction devices for abdominal wall reconstruction, serving hospitals, ICUs, and surgical departments treating open abdomen, complex hernia, and pediatric congenital defect cases.

Ownership category

akta.pro rank

Product category

Surgical Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Abdominal wall reconstruction
• Medical devices
• Fascial traction
• Open abdomen therapy
• Hernia repair

Headquarters

HQ city

Cologne

HQ country

Germany

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Medical Device Sales: Fasciotens generates revenue through the sale of proprietary medical devices for abdominal wall reconstruction. The company offers three main product lines: fasciotens®Abdomen for open abdomen therapy, fasciotens®Hernia for complex hernia repair, and fasciotens®Pediatric for congenital abdominal wall defects in newborns. Sales appear to be directed toward hospitals and surgical departments.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Fasciotens develops and sells proprietary medical devices that apply controlled fascial traction to the abdominal wall. Its portfolio includes fasciotens®Abdomen for open abdomen therapy in ICU settings, fasciotens®Hernia for complex hernia repair, and fasciotens®Pediatric for congenital abdominal wall defects in newborns. The devices are sold to hospitals and surgical departments, with case discussion, e-learning, and clinical publications supporting adoption.

Product overview

Fasciotens offers a portfolio of three specialized medical devices for abdominal wall reconstruction: fasciotens® Abdomen for open abdomen therapy in intensive care settings, fasciotens® Hernia for complex hernia repair, and fasciotens® Pediatric for congenital abdominal wall defects in newborns. The company also provides complementary services including e-learning courses (academy.fasciotens.com) and case discussion consultations with surgeon experts.

Differentiator

Problem solved

Functional benefit

Brands

• fasciotens®Abdomen: Device for open abdomen treatment that increases intra-abdominal volume to create more space for organs, stabilize patients, and facilitate fascial closure.
• FASCIOTENS®HERNIA
• FASCIOTENS®PEDIATRIC

Products and services

• fasciotens®Abdomen Medical device for open abdomen therapy that increases intra-abdominal volume to create more space for organs, stabilizes patients, facilitates fascial closure, and reduces the need for revision surgeries due to dynamic changes in traction. Sold to hospitals and intensive care units treating patients requiring temporary abdominal closure.
• fasciotens®Hernia Medical device for complex hernia surgery that stretches the abdominal wall and helps restore anatomical integrity while keeping the lateral abdominal wall intact. Designed to be easily learned and combined freely with other surgical techniques, sold to surgical departments performing complex hernia repairs.
• fasciotens®Pediatric Medical device for treating congenital abdominal wall defects in newborns such as gastroschisis or omphaloceles. Enlarges the abdominal cavity in a standardized and reproducible way to create space for organs and achieve definitive closure in large defects. Sold to neonatal and pediatric surgical units.

Quantifiable outcome

• 25 cm midline incisional hernia recurrence closed after 25 minutes with fasciotens BTA pre-treatment
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Local Distribution PartnerscoreChannel Partner/ Reseller/ DistributorFasciotens maintains a network of local distribution partners referenced on their website contact page. These partners handle regional distribution of fasciotens medical devices to hospitals and surgical departments. Specific partner names are not disclosed on the main website.

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Becton, Dickinson and Company (BD): BD's surgical and interventional segments include hernia fixations, biosurgery, and OR consumables that compete for the same hospital wallet as Fasciotens devices, especially in hernia and open-abdomen procedures.
• Cook Medical: Cook Medical manufactures a broad surgical portfolio including hernia and wound-care devices used in abdominal wall reconstruction, comparable to Fasciotens' surgical-device focus and hospital-channel GTM.
• Integra LifeSciences: Integra sells regenerative tissue technologies, specialty surgical supplies, and ENT/neuro products. It overlaps with Fasciotens in soft-tissue reconstruction and surgical wound management devices for the same hospital surgeon customers.
• Ethicon (Johnson & Johnson MedTech): Ethicon is J&J's surgical franchise and a dominant supplier of hernia meshes, fixation devices, sutures, and staplers. It overlaps with Fasciotens in complex hernia repair workflows where surgeons choose between conventional mesh-based closure and traction-assisted techniques.
• Medtronic: Medtronic's Surgical Innovations and Patient Monitoring businesses sell hernia meshes, fixation devices, and ICU monitoring used in similar operating-room and intensive-care workflows as Fasciotens devices.

Direct peers

• W. L. Gore & Associates (Gore Medical): Gore Medical supplies Gore-Tex and other surgical meshes used in hernia and abdominal wall repair. It is a direct comparable in the complex hernia indication where Fasciotens competes for procedure share on large and recurrent hernias.
• TELA Bio: TELA Bio is a focused hernia and soft-tissue reconstruction device company selling biologic and synthetic reinforcement products. It addresses the same surgical decision point as Fasciotens' complex hernia product for ventral hernia repair.

Emerging players

• Deep Blue Medical: Deep Blue Medical is an emerging company developing novel hernia-repair mesh and fixation devices, making it a relevant smaller-stage comparator pursuing product innovation in the same abdominal wall reconstruction category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/fasciotens-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fasciotens